ENVB Stock Analysis: Buy, Sell, or Hold?
ENVB - Enveric Biosciences, Inc. Common Stock
$5.14
-0.18 (-3.38%)
▼
5d:
+42.78%
30d:
+187.16%
90d:
+47.28%
WAIT
LOW Confidence
Analysis Updated: Apr 29, 2026 12:00 AM ET
Earnings: May 13, 2026
13d
Get Alerted When ENVB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ENVB is 32.1% above its trading range ($3.89). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ENVB is 32.1% above its trading range ($3.89). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ENVB is currently trading at $5.14, which is considered extended relative to its 30-day fair value range of $1.51 to $3.89.
Technical Outlook: Technically, ENVB is in a downtrend. Immediate support is located at $1.71, while resistance sits at $7.88. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: ENVB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+88.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ENVB is in a downtrend. Immediate support is located at $1.71, while resistance sits at $7.88. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: ENVB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+88.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.51 -
$3.89
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
42.1%
All Signals
- BEARISH: Price significantly overextended (+32.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 88.0% below Wall St target ($10.00)
Trading Range Analysis
30-Day Trading Range
$1.51 -
$3.89
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.71
Resistance Level
$7.88
Current Trend
Downtrend
Technical data as of
Apr 29, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.09
Wall Street Target
$10.00
(+88.0%)
Revenue Growth (YoY)
-7.3%
Share & Embed Analysis
Last updated: April 29, 2026 3:39 PM ET
Data refreshes hourly during market hours. Next update: 4:39 PM
Data refreshes hourly during market hours. Next update: 4:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENVB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$131 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$27 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 50 HOLD |
|
EXEL
Exelixis Inc |
BUY
20 analysts |
$48 | 62 BUY |
